Jake K. Whang
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Adjunctive and supportive strategies to mitigate drug toxicities in the treatment of nontuberculous mycobacterial disease with future directions.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: September 22, 2025
Methyl jasmonate promotes host defense by activating autophagy during Mycobacterium tuberculosis infection.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 14, 2025
Association between nutritional status and clinical characteristics in nontuberculous mycobacterial pulmonary disease: preliminary results from the NTM-KOREA cohort.
Journal: Respiratory research
Published: August 09, 2025
Trends and Sociodemographic Characteristics of Nontuberculous Mycobacterial Infections in South Korea: A Nationwide NHIS-Based Study (2010-2022).
Journal: Tuberculosis and respiratory diseases
Published: July 30, 2025
Trends and Sociodemographic Characteristics of Nontuberculous Mycobacterial Infections in South Korea: A Nationwide NHIS-Based Study (2010-2022).
Journal: Tuberculosis and respiratory diseases
Published: July 30, 2025
Secreted Chorismate Mutase: A Novel Prognostic Factor in Mycobacterium intracellulare Pulmonary Disease.
Journal: The Journal of infectious diseases
Published: February 21, 2025
Restriction of mitochondrial oxidation of glutamine or fatty acids enhances intracellular growth of Mycobacterium abscessus in macrophages.
Journal: Virulence
Published: January 19, 2025
BACES score: a predictor of health-related quality of life and associated factors in patients with nontuberculous mycobacterial pulmonary disease.
Journal: Scientific reports
Published: November 17, 2024
Integrated analysis of miRNA and transcription factor gene expression profiles associated with anti-tuberculosis treatment responses.
Journal: BMC infectious diseases
Published: September 17, 2024
High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis.
Journal: Tuberculosis and respiratory diseases
Published: July 12, 2024
Last Updated: 09/26/2026